Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.

World journal of gastroenterology - 14 Oct 2016

Merli Michele, Carli Giuseppe, Arcaini Luca, Visco Carlo

Abstract excerpt

The association of hepatitis C virus (HCV) and B-cell non-Hodgkin lymphomas (NHL) has been highlighted by several epidemiological and biological insights; however the most convincing evidence is represented by interventional studies demonstrating the capability of antiviral treatment (AT) with interferon (IFN) with or without ribavirin to induce the regression of indolent lymphomas, especially of marginal-zone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Clinical Trials as Topic
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferons

Share to Lymphoma, B-Cell

Share to Ribavirin

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 27784957
DOI: 10.3748/wjg.v22.i38.8447
PMCID: PMC5064026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.PMID 27784957Read ↗

Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.Semantic proximity Read ↗

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.Semantic proximity Read ↗

Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.Semantic proximity Read ↗

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.Semantic proximity Read ↗

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.Semantic proximity Read ↗

Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.Semantic proximity Read ↗

Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection.Semantic proximity Read ↗

Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.Semantic proximity Read ↗

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study.Semantic proximity Read ↗

Hepatitis C virus in non-Hodgkin's lymphoma. A reappraisal after a prospective case-control study of 300 patients. Lombart Study Group of HCV-Lymphoma.Semantic proximity Read ↗

HCV and LymphoproliferationSemantic proximity Read ↗

Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.